Compounds > 4-(n,n-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole
Page last updated: 2024-12-07

4-(n,n-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(N,N-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole: used for the determination of medroxyprogesterone acetate in serum; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131382
SCHEMBL ID9780063
MeSH IDM0215333

Synonyms (22)

Synonym
4-benzofurazansulfonamide, 7-hydrazino-n,n-dimethyl-
dbd-h
4-(n,n-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole
131467-86-2
4-(n,n-dimethylaminosulfonyl)-7-hydrazinobenzofurazan
7-hydrazinyl-n,n-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide
4-(n,n-dimethylsulfamoyl)-7-hydrazino-benzofurazan
SCHEMBL9780063
2,1,3-benzoxadiazole-4-sulfonamide, 7-hydrazino-n,n-dimethyl-
DTXSID10157059
AKOS028108576
4-(n,n-dimethylsulfamoyl)-7-hydrazino-benzofurazan, for fluorescence, >=97.0% (chn)
mfcd00191376
J-006008
4-(n,n-dimethylaminosulphonyl)-7-hydrazino-2,1,3-benzoxadi-azole
dbd-h [=4-(n,n-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole] [for hplc labeling]
7-hydrazinyl-n,n-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide
D95242
2,1,3-benzoxadiazole-4-sulfonamide, 7-hydrazinyl-n,n-dimethyl-
CS-0361116
dimethylaminosulfonylhydrazinobenzoxadiazole
BS-43862
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.59 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
xanthine
7H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-7 is protonated.. 9H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-9 is protonated.		210xanthineSaccharomyces cerevisiae metabolite
2,2'-azobis(2-amidinopropane)
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator		210monoazo compound
pregnenolone
[no description available]		3.11020-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
C21-steroid		human metabolite;
mouse metabolite
glycerylphosphorylcholine
Glycerylphosphorylcholine: A component of PHOSPHATIDYLCHOLINES or LECITHINS, in which the two hydroxy groups of GLYCEROL are esterified with fatty acids. (From Stedman, 26th ed)		210glycerophosphocholine
phenyl acetate
phenyl acetate: The ester formed between phenol and acetic acid. Don't confuse with phenylacetic acid derivatives listed under PHENYLACETATES.. phenyl acetate : An acetate ester obtained by the formal condensation of phenol with acetic acid.		3.110benzenes;
phenyl acetates
hydroxyl radical
Hydroxyl Radical: The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.		210oxygen hydride;
oxygen radical;
reactive oxygen species
2-butenal
crotonaldehyde : An enal consisting of propene having a formyl group at the 1-position.		2.110enal
2-hexenal, z-isomer
2-hexenal: product of lipid peroxidation in the rat liver; a green odor chemical; do not confuse with the hexabarbital synonym, hexenal; RN given refers to cpd without isomeric designation. 2-hexenal : A hexenal having the double bond at the 2-position.. (2E)-hexenal : A 2-hexenal in which the olefinic double bond has E configuration. It occurs naturally in a wide range of fruits, vegetables, and spices.		2.1102-hexenalantibacterial agent;
flavouring agent;
plant metabolite
4-hydroxy-2-nonenal
4-hydroxy-2-nonenal: cytotoxic product from peroxidation of liver microsomal lipids; RN given refers to cpd without isomeric designation. 4-hydroxynon-2-enal : An enal consisting of non-2-ene having an oxo group at the 1-position and a hydroxy group at the 4-position.. 4-hydroxynonenal : A monounsaturated fatty aldehyde that is nonanal that has undergone dehydrogenation to introduce a double bond at any position in the aliphatic chain and in which a hydrogen at position 4 has been replaced by a hydroxy group.		7.1104-hydroxynon-2-enal;
4-hydroxynonenal
oxadiazoles
Oxadiazoles: Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms.		4.2250
allopurinol
Allopurinol: A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.. allopurinol : A bicyclic structure comprising a pyrazole ring fused to a hydroxy-substituted pyrimidine ring.		210nucleobase analogue;
organic heterobicyclic compound		antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
ConditionIndicatedRelationship StrengthStudiesTrials
Rheumatoid Arthritis
[description not available]		02.520
Arthritis, Rheumatoid
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.		02.520
Diabetes Mellitus
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.		02.110